Skip to main content
Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Important information

The contents of this webpage are in French only.

Décision relative à la demande d’accès 7212-2025-02595

Document administratif
Updated on

 08 May 2025

La demande d’accès concerne des documents divers relatifs au médicament biologique Risankizumab pour le psoriasis en plaques.